Et dobbeltblindt, randomiseret, enkeltdosis overkrydsningsforsøg med 24 raske frivillige viste, at Valtropins farmakokinetiske profil var sammenligneligt med referenceproduktet.
A double-blind, randomised, single dose, crossover study in 24 healthy volunteers showed that the pharmacokinetic profile of Valtropin was comparable to that of the reference product.